-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Srixon Announces Buy 2, Get 1 Free Golf Ball Promotion
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
-
Who Is the Best Spanish-Speaking Private Investigator in Sacramento?
-
Healixa Turns Patents Into Products: FrostPulse(TM) Delivered and Five Eternal Spring(TM) Units Enter Production
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
-
Nearly Half of Transformation Initiatives Face a 'Momentum Gap' That Puts Value at Risk, NSP & Company Study Finds
-
CXAI Expands Agentic AI Reach into Mid-Market Through EngineRoom's Simpro Partnership
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Agency Guacamole's 10th B.L.N.D. Event Brought Industry Leaders Together for a Conversation on the Evolution of Diversity and Inclusion in Beauty
-
From Pilot to Production: InHand Networks' Practical Approach to Industrial Edge AI
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
Bill introduced by Senators Sheehy and Klobuchar would replace a looming product ban with clear, enforceable federal standards permitting the continued sale of most current lawful hemp-derived products
CHARLOTTE, NC / ACCESS Newswire / November 18, 2026 / cbdMD, Inc. (NYSE American:YCBD), a leading hemp and wellness company, today announced its support for the Hemp Guardrails Act, bipartisan legislation introduced on November 17 by Senators Tim Sheehy (R-MT) and Amy Klobuchar (D-MN). The bill would establish a federal regulatory framework for hemp-derived products and avert the December 11, 2026 implementation of a redefinition that would effectively ban many lawful products nationwide.
"The Hemp Guardrails Act gets this right: it protects consumers without destroying an American industry," said Ronan Kennedy, Chief Executive Officer of cbdMD. "Responsible operators have asked for real rules for years. This bill delivers them, with age-21 sales, child-resistant packaging, third-party testing, FDA manufacturing standards and clear labeling, while preserving the farms, manufacturers and retailers that support an estimated 350,000 American jobs."
Protecting consumers
The legislation would:
- Restrict hemp-derived cannabinoid products to adults 21 and older
- Require child-resistant packaging and QR codes linking to third-party certificates of analysis
- Direct FDA to set manufacturing, testing, facility registration and recall standards
- Prohibit hemp products from containing more than trace amounts of intoxicating cannabinoids other than delta-9 THC, and a few other compounds
- Maintain the prohibition on synthetic cannabinoids that do not occur naturally in the hemp plant
- Require hemp to be grown, processed and packaged in the United States
Protecting jobs and tax revenue
Without congressional action, the hemp redefinition taking effect December 11 would remove a broad range of lawful products from the market. Industry estimates put the jobs supported by the hemp sector at approximately 350,000, spanning American farmers, manufacturers, distributors and retailers. The industry also generates substantial tax revenue for states and local communities. The Hemp Guardrails Act would preserve that economic activity while giving regulators the tools to remove bad actors.
"A ban doesn't make anyone safer. It pushes consumers toward unregulated products and costs Americans their jobs," Kennedy added. "We urge Congress to include the Hemp Guardrails Act in the year-end funding package before December 11."
A diversified platform built for regulatory change
cbdMD's recent acquisition of the Twinlab, Metabolife and Reserveage brands has added an established portfolio of nutritional supplements that does not rely on hemp-derived cannabinoids. Unlike many hemp-focused peers that depend entirely on cannabinoid products, cbdMD now operates a diversified wellness platform that helps de-risk the business against federal and state regulatory change, whatever the outcome in Congress.
"We support smart regulation because it's right for consumers and for the industry. We've also built cbdMD to perform through regulatory change," said Kennedy. "Twinlab gives us scale and diversification across the broader supplement market, and if this legislation passes, it opens a clear federal pathway for hemp-derived dietary supplements that our combined portfolio is well positioned to serve."
cbdMD has long invested in product safety, including third-party testing of its products and published research on its ingredients. The company stands ready to work with lawmakers and FDA on implementation.
About cbdMD, Inc.
cbdMD, Inc. (NYSE American:YCBD) is a wellness company headquartered in Charlotte, North Carolina, whose portfolio spans the fundamentals to the frontier of wellness. The Company's brands include Twinlab, Reserveage, Metabolife, ResVitale, cbdMD, Paw CBD, Oasis and Bluebird Botanicals, offered through retail, wholesale and direct-to-consumer channels. Guided by the promise of More Life in Every Day, cbdMD is committed to quality, transparency and innovation. To learn more, visit www.cbdmd.com.
Forward-Looking Statements
This press release contains statements, estimates, forecasts, and projections regarding future performance and events that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Those statements include statements regarding expectations from the proposed bill, the probability of the passing of the bill or the passing of the bill in its current form, integration of the Twinlab assets, revenue growth, potential efficiencies resulting from the acquisition and new product offerings. These statements may be identified by the use of words like "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "will," "should," and "seek," and similar expressions set forth herein. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those projected in the forward-looking statements. Important factors and risks that could cause actual results to differ materially from our expectations include, but are not limited to, the successful passing of the bill in its current form and continued regulatory compliance , as well as those risks detailed in our filings with the SEC, including our most recent Form 10-K and other filings with the SEC. The Company undertakes no obligation to update any forward-looking statement, except as required by law.
Contacts
cbdMD, Inc.
Ronan Kennedy
Chief Executive Officer and Chief Financial Officer
[email protected]
(704) 445-3064
SOURCE: cbdMD
View the original press release on ACCESS Newswire
Th.Gonzalez--AT